November 12th 2024
A 12-week regimen showed significant reductions in wrinkle severity and pigment improvement.
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
The current and emerging state of noninvasive body contouring
April 21st 2020At the most recent ASDS meeting, Catherine DiGiorgio, M.D., Boston, discusses the current state of noninvasive body contouring, and what noninvasive devices and procedures will soon hit the market including a collagenase clostridium histolyticum injection and cellulite-targeting devices that use electromagnetic stimulation and radiofrequency.
COVID-19: Survival of the Private Practice
April 21st 2020We brought physician and industry leaders together last week for a live webinar to examine the current state of the private practice as well as its viability over the next few months. Our panel offered insights and inspiration for remaining productive, proactive and positive as we work towards a return to business.
Red light treatment proves safe, effective for androgenetic alopecia
April 6th 2020REVIAN Inc. releases data from their investigational study examining their REVIAN RED dual wavelength LED light treatment for androgenetic alopecia, showing the FDA-cleared device to be both safe and effective at week 16 in a 26-week trial.
Microneedling plus radiofrequency effective
April 2nd 2020Glynis R. Ablon, M.D., spoke at the 18th annual South Beach Symposium in Miami about why microneedling with radiofrequency is an effective way to combat signs of aging skin. According to Dr. Ablon, benefits include minimal downtime and risk versus other options.
Real Simple Talks Keloid Scar Prevention
March 30th 2020This week, Allure explains telemedicine and reasons for always wearing SPF, even indoors. Self questions a COVID-19 vaccine, and the effectiveness of pimple patches, while Shape explains Nutrafol for hair and Real Simple talks keloid scar prevention. As a bonus, Elle demonstrates that the Brits can still find the funny in even the bleakest times of Coronavirus.